CN-PPV Polymer Nanoparticles for Bioimaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current semiconducting polymer dots (Pdots) face challenges in achieving both nanoscopic size and strong photoluminescence, as smaller particles tend to self-quench and larger ones disrupt biological functions and have poor mass transfer and tissue penetration, making it difficult to develop highly fluorescent nanoparticles for bioimaging.
Innovation Solution
The development of poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-(1-cyanovinylene-1,4-phenylene) nanoparticles (CN-PPV Pdots) that are optimized for small size and high fluorescence, with a critical dimension of 1 nm to 1000 nm, allowing minimal disruption to biological targets while maintaining strong photoluminescence for bioimaging applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If polymer dots are made smaller to reduce disruption to biological targets, then biocompatibility is improved, but fluorescence intensity decreases due to self-quenching
Solution Approach 1:
The patent applies parameter changes by optimizing the critical dimensions of polymer dots to a specific nanoscopic range (1-1000 nm) where they maintain both small size for biocompatibility and sufficient fluorescence intensity. This size parameter optimization resolves the contradiction between minimizing biological disruption and maintaining photoluminescence strength.
Solution Approach 2:
The patent uses composite materials by combining semiconducting polymers with specific molecular structures (containing electron-donating and electron-withdrawing groups) to create polymer dots that exhibit both small nanoscopic size and high quantum yield, overcoming the self-quenching issue that plagues smaller particles.
2Illumination intensity
If polymer dots are made larger to maintain strong photoluminescence, then fluorescence intensity is improved, but mass transfer and tissue penetration deteriorate
Solution Approach 1:
The patent optimizes the size parameter of polymer dots to a nanoscopic range (1-1000 nm) that balances fluorescence intensity with mass transfer capability. This critical dimension optimization enables both strong photoluminescence and adequate tissue penetration, resolving the contradiction between these two parameters.
3Reliability
If polymer dots are made larger to reduce self-quenching, then quantum yield is improved, but tissue penetration deteriorates
Solution Approach 1:
The patent identifies and optimizes the critical dimension parameter of polymer dots to a specific nanoscopic range where quantum yield is sufficiently high without requiring large particle sizes. This parameter optimization resolves the contradiction between achieving high quantum yield and maintaining small size for tissue penetration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
CN-PPV Pdots exhibit high quantum yield and fast emission rates, providing bright and specific labeling of cellular structures with minimal nonspecific binding, making them suitable for advanced bioimaging and bioanalytical assays.
Implementation Method 1
illuminating the nanoparticle with electromagnetic radiation sufficient to produce a fluorescence signal; detecting the fluorescence signal
Implementation Method 2
CN-PPV Pdots exhibit high quantum yield and fast emission rates, providing bright and specific labeling of cellular structures
Data Source
AI summary
Fluorescent nanoparticles are provided. The nanoparticles are formed from poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-(1-cyanovinylene-1,4-phenylene)]. Also provided are methods for imaging a target to which the nanoparticles are bound.